Background/Aims: Biliary atresia (BA) is a cholangio-destructive disease of the infant liver presenting with features of obstructive cholangiopathy. The Kasai portoenterostomy (KPE) is the first line of management. The aim of our study was to identify the characteristic features of liver histology in BA that impact the outcome of KPE. Patients and Methods: Data from 30 consecutive children was retrieved from our prospectively maintained database of children undergoing KPE. This included basic demographics, laboratory values and histopathological data from liver biopsy. The stages of fibrosis, presence of ductal plate malformation (DPM), giant cell transformation, extramedullary hematopoiesis and area percentage of α-SMA (α-smooth muscle act...
Aim: To grade histopathological parameters in biliary atresia (BA) and correlate it with advancing a...
BACKGROUND: The progression of hepatic fibrosis may result in decompensated hepatic failure with cir...
Background: Outcomes in biliary atresia (BA) have been well-documented in large national cohorts fro...
Background. In biliary atresia mechanisms of progressive liver injury leading to need of liver trans...
Biliary atresia (BA) is a chronic neonatal cholangiopathy characterized by fibroinflammatory bile du...
Context: Biliary atresia (BA) is a destructive process affecting both extra-and intra-hepatic bile d...
Although biliary obstruction in extrahepatic biliary atresia (EHBA) patients can be surgically allev...
Successful portoenterostomy (SPE) improves the short-term outcome of patients with biliary atresia (...
Patients with Alagille syndrome (AGS), a genetic disorder of Notch signaling, suffer from severe duc...
The progression of hepatic fibrosis may result in decompensated hepatic failure with cirrhosis, live...
Abstract Background Young age at portoenterostomy has...
Biliary atresia is the commonest cause of pathological jaundice in infants. The aetiology and pathog...
Background The cellular origin of myofibroblast in the liver fibrosis remains unclear. This study wa...
Background: Biliary atresia (BA) is a rare obliterative cholangiopathy and Kasai portoenterostomy (K...
Biliary atresia (BA) is a cholangiodestructive disease affecting biliary tract, which ultimately lea...
Aim: To grade histopathological parameters in biliary atresia (BA) and correlate it with advancing a...
BACKGROUND: The progression of hepatic fibrosis may result in decompensated hepatic failure with cir...
Background: Outcomes in biliary atresia (BA) have been well-documented in large national cohorts fro...
Background. In biliary atresia mechanisms of progressive liver injury leading to need of liver trans...
Biliary atresia (BA) is a chronic neonatal cholangiopathy characterized by fibroinflammatory bile du...
Context: Biliary atresia (BA) is a destructive process affecting both extra-and intra-hepatic bile d...
Although biliary obstruction in extrahepatic biliary atresia (EHBA) patients can be surgically allev...
Successful portoenterostomy (SPE) improves the short-term outcome of patients with biliary atresia (...
Patients with Alagille syndrome (AGS), a genetic disorder of Notch signaling, suffer from severe duc...
The progression of hepatic fibrosis may result in decompensated hepatic failure with cirrhosis, live...
Abstract Background Young age at portoenterostomy has...
Biliary atresia is the commonest cause of pathological jaundice in infants. The aetiology and pathog...
Background The cellular origin of myofibroblast in the liver fibrosis remains unclear. This study wa...
Background: Biliary atresia (BA) is a rare obliterative cholangiopathy and Kasai portoenterostomy (K...
Biliary atresia (BA) is a cholangiodestructive disease affecting biliary tract, which ultimately lea...
Aim: To grade histopathological parameters in biliary atresia (BA) and correlate it with advancing a...
BACKGROUND: The progression of hepatic fibrosis may result in decompensated hepatic failure with cir...
Background: Outcomes in biliary atresia (BA) have been well-documented in large national cohorts fro...